The purpose of the Heidelberg Registry of Atrial Fibrillation (HERA-FIB) is to collect data on the prevalence and clinical significance of elevated cardiac troponin in a large registry of unselected patients with atrial fibrillation presenting to an emergency department in the era of novel oral anticoagulants (NOACs).
Study Type
OBSERVATIONAL
Enrollment
5,000
Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital
Heidelberg, Baden-Wurttemberg, Germany
RECRUITINGVascular and non-vascular death
Time frame: Follow up after at least 6 months
Nonfatal myocardial infarction
Time frame: Follow up after at least 6 months
Stroke/systemic embolism
Time frame: Follow up after at least 6 months
Stroke, systemic embolism, myocardial infarction, vascular death, non-vascular death, composite endpoint of vascular and non-vascular death, nonfatal MI, stroke/systemic embolism
Time frame: Follow up after at least 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.